Safety and Immunogenicity of Heptavalent Pneumococcal Vaccine Conjugated to CRM197 Among Infants With Sickle Cell Disease

Katherine L. O’Brien(Johns Hopkins University), Howard M. Lederman(Johns Hopkins Medicine), Allen E. Eskenazi(University of Maryland, Baltimore), Ruth E. Luddy(Sinai Hospital), Jeffrey T. Nold, Mathuram Santosham(Johns Hopkins University), Sally Snader(Johns Hopkins University), Jerry A. Winkelstein(Johns Hopkins University), Andrea J. Swift(Johns Hopkins University), Beth Stover(Johns Hopkins University), Joseph E. Gootenberg(National Cancer Institute)
PEDIATRICS
November 1, 2000
10.1542/peds.106.5.965
Cited by 103

Related Papers

Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study
|The Lancet|2017|2.4k
Global burden of childhood pneumonia and diarrhoea
|The Lancet|2013|2.4k
Chronic Granulomatous Disease: Report on a National Registry of 368 Patients
|Medicine|2000|1.7k
Burden of Streptococcus pneumoniae and Haemophilus influenzae type b disease in children in the era of conjugate vaccines: global, regional, and national estimates for 2000–15
|The Lancet Global Health|2018|1.2k
JM2, encoding a fork head–related protein, is mutated in X-linked autoimmunity–allergic disregulation syndrome
|Journal of Clinical Investigation|2000|930